Average cost of a family health insurance plan now nearly $27,000

Employer-sponsored family health insurance costs are projected to reach nearly $27,000 in 2025, marking a 6% increase, or $1,408, from the prior year, according to KFF's annual survey. This rise, double the inflation rate and consistent with previous years' increases, is primarily driven by escalating healthcare spending, particularly drug prices like GLP-1s, chronic disease prevalence, and hospital costs. With 43% of the largest firms now covering GLP-1s for weight loss, up from 28% in 2024, premiums are expected to climb even more sharply next year. Consequently, employers, lacking new cost-control strategies, are likely to shift more expenses to employees through higher deductibles, which already average nearly $1,900 for individual plans, indicating a sustained upward pressure on corporate benefits spending and individual healthcare burdens.

Analysis

Employer-sponsored family health insurance costs are projected to reach nearly $27,000 in 2025, representing a 6% year-over-year increase of $1,408, which is double the current inflation rate. This marks the third consecutive year of significant premium hikes, following 7% increases in each of the prior two years. Workers now contribute an average of $6,850 annually towards family coverage, highlighting the growing financial burden on employees.

The primary drivers for these escalating costs are increased healthcare spending, particularly rising prescription drug prices, chronic disease prevalence, and higher utilization of services. Notably, GLP-1 drugs, such as Wegovy and Zepbound, are a significant factor, with 43% of the largest firms now covering these weight-loss treatments, up from 28% in 2024. This trend suggests a structural shift in pharmaceutical expenditure within corporate benefits.

Beyond premiums, individual deductibles have also climbed to nearly $1,900, with small firm employees facing significantly higher out-of-pocket expenses, often exceeding $2,000. KFF anticipates that employers, lacking effective strategies to mitigate rising healthcare costs, will increasingly shift financial responsibility to employees through higher deductibles and other forms of cost-sharing. This indicates sustained upward pressure on corporate benefits budgets and individual healthcare burdens, with KFF CEO Drew Altman forecasting even sharper premium increases next year.

Key Decisions for Investors

• Monitor corporate earnings calls for commentary on rising benefits costs and their impact on operating margins, as these expenses are increasing significantly.
• Evaluate investment opportunities in the pharmaceutical sector, particularly companies developing GLP-1 drugs, given the accelerating employer coverage and demand for these treatments.
• Assess the potential impact of increased employee healthcare cost-sharing on consumer discretionary spending and the broader economic outlook, especially for sectors reliant on middle-income consumers.
• Consider the competitive implications for small and medium-sized enterprises (SMEs) regarding talent acquisition and retention, given their employees face substantially higher deductibles.